AQUALYX is an innovative injectable lipolysis solution designed to reduce localized fat deposits in various areas of the body. It is a water-based solution containing sodium deoxycholate, which helps break down fat cells without damaging surrounding tissues. The product is effective in contouring the body, eliminating fat lumps, and reducing localized fat deposits, especially in problematic areas such as the chin, abdomen, thighs, and buttocks.
The product is manufactured by Marcos S.r.l., Italy — a recognized leader in the field of aesthetic medicine and dermatology.
Composition. Methods and Application.
Composition:
AQUALYX contains the active ingredient sodium deoxycholate (0.7% solution). This substance affects the cell membranes of fat cells, breaking them down and eliminating them through the lymphatic system. The formulation also includes excipients that ensure the stability of the solution and its even distribution during injection.
Methods and Application:
he product is injected into the subcutaneous fat tissue. The procedure is carried out by a qualified specialist in a medical setting. The number of injections depends on the treatment area, the size of fat deposits, and the individual characteristics of the patient. Typically, achieving the desired result requires between 2 and 6 sessions, with intervals of 3-4 weeks. AQUALYX is administered with fine needles, causing minimal discomfort, which makes the procedure comfortable for patients.
AQUALYX is recommended for areas where stubborn fat deposits are localized and cannot be reduced through traditional methods such as dieting or exercise. Injectable lipolysis can be used for both aesthetic purposes (e.g., reducing fat deposits under the chin) and medical purposes (e.g., body contouring after significant weight changes).
Contraindications.
AQUALYX has several contraindications that must be considered before use:
- Individual hypersensitivity to any of the components of the product, including sodium deoxycholate.
- Active inflammatory skin conditions at the injection site (e.g., dermatitis, eczema, acne).
- Pregnancy and breastfeeding — the use of the product is not recommended during these periods, as its effects on maternal and infant health have not been studied.
- Liver or kidney function disorders, as the product is eliminated through the lymphatic system and kidneys, and impaired function of these organs may hinder proper elimination.
- Vascular conditions in the injection area (e.g., varicose veins).
- Oncological diseases and conditions that affect the immune system.
- Age under 18 or over 65 — injectable lipolysis may carry increased risks for patients in these age groups.
- Active infections or damage to the skin at the injection site.
Before undergoing the procedure, it is essential to have a consultation with a doctor to exclude any possible contraindications and to develop an individualized treatment plan.
This description is for informational purposes only.
